{
    "Trade/Device Name(s)": [
        "Liquichek Maternal Serum II Control"
    ],
    "Submitter Information": "Bio-Rad Laboratories",
    "510(k) Number": "K143379",
    "Predicate Device Reference 510(k) Number(s)": [
        "K984594"
    ],
    "Regulatory Class": "Class I, Reserved",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "February 9, 2015",
    "Summary Letter Received Date": "February 11, 2015",
    "Submission Date": "March 12, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality Control Material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "AFP",
        "hCG",
        "Unconjugated Estriol",
        "Inhibin A"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Bio-Rad Liquichek Maternal Serum II Control, an assayed quality control serum for maternal analytes.",
    "Indications for Use Summary": "Intended for use as an assayed quality control serum to monitor the precision of laboratory testing procedures for the listed analytes.",
    "fda_folder": "Clinical Chemistry"
}